Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

14281006 206891 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 206891 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281026 167971 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167971 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281025 206785 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 206785 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1711 77 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
5310983 77 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
CHEMBL336208 77 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
3352 2371 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5280879 2371 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5863 2371 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
CHEMBL509456 2371 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
1756 463 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5310954 463 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL336292 463 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5492386 206486 4 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 206486 4 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
135434015 203924 11 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 203924 11 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
14281041 206983 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91359 206983 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 106131 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 106131 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135409400 204901 77 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
CHEMBL760 204901 77 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
15005606 206557 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 206557 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281012 106009 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL313282 106009 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
14281011 206815 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 206815 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
15005605 206558 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 206558 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005586 106924 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106924 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 206904 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 206904 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281001 207147 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 207147 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281010 206999 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 206999 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281011 206815 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 206815 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
440317 21748 17 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
CHEMBL131890 21748 17 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
15005591 206506 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88377 206506 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005580 206773 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 206773 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281024 206564 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 206564 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281020 106539 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314093 106539 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 106131 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 106131 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281023 206927 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91044 206927 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005608 206954 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 206954 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281005 207362 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 207362 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005569 111459 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
CHEMBL327580 111459 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
5492386 206486 4 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 206486 4 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281004 206982 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 206982 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
15005588 207148 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 207148 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005581 206915 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90958 206915 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280996 207042 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL91634 207042 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
14280992 206528 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88525 206528 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005576 206514 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 206514 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005584 206779 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 206779 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005574 207021 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 207021 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
5487281 206538 14 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 206538 14 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
14281001 207147 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 207147 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281015 111576 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111576 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005605 206558 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 206558 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
10016898 206847 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90566 206847 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005600 206483 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88224 206483 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
136677322 3296 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
1739 3296 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
656725 3296 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
CHEMBL1160031 3296 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
14281027 206698 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL89679 206698 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005586 106924 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106924 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005573 206979 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL91340 206979 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
15005599 206554 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88697 206554 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281000 206694 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
CHEMBL89660 206694 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
15005601 111797 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL328755 111797 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005566 206584 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 206584 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005603 164113 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 164113 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112638 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112638 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005571 206970 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91295 206970 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1713 520 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5957 520 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
91 520 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14249 520 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
DB00171 520 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
14281034 111427 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL327374 111427 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005572 163814 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163814 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
15005566 206584 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 206584 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005564 165424 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 165424 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005578 207030 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 207030 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
5487281 206538 14 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 206538 14 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
15005594 206867 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL90677 206867 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281005 207362 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 207362 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005584 206779 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 206779 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
9999105 206481 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88218 206481 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
135973538 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
1728 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
2966 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
4261196 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
5361 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
CHEMBL265502 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
DB04786 3710 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
15005608 206954 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 206954 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281003 206961 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
CHEMBL91259 206961 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
15005603 164113 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 164113 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005598 206560 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88730 206560 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005602 206940 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91127 206940 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135434015 203924 11 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 203924 11 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
15005578 207030 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 207030 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
14281031 207087 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91899 207087 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005606 206557 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 206557 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281026 167971 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167971 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281016 206986 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 206986 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281018 207162 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL92363 207162 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281036 206555 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
CHEMBL88698 206555 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
15005592 206767 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 206767 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005572 163814 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163814 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
44323790 206569 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 206569 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281024 206564 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 206564 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005574 207021 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 207021 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005592 206767 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 206767 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005585 207015 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 207015 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 206904 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 206904 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281006 206891 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 206891 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
134687118 192783 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5179763 192783 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5221347 192783 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
14281008 206595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88955 206595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005588 207148 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 207148 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112638 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112638 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005564 165424 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 165424 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005604 206490 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88265 206490 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005590 206576 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL88835 206576 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
10017729 206463 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 206463 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1712 288 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
6022 288 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14830 288 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
135838395 106152 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
CHEMBL313609 106152 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
14281016 206986 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 206986 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281010 206999 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 206999 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005580 206773 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 206773 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281033 112803 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330677 112803 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281004 206982 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 206982 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
14281025 206785 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 206785 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005576 206514 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 206514 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1755 289 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5310996 289 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL335206 289 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
10017729 206463 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 206463 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281035 206725 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL89876 206725 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005567 207076 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91837 207076 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281015 111576 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111576 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005585 207015 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 207015 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005577 206458 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 206458 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14280999 206510 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL88395 206510 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
15005570 207032 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
CHEMBL91579 207032 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
14280998 207078 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91843 207078 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005583 207125 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92158 207125 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
44323790 206569 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 206569 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
15005577 206458 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 206458 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
44443919 94416 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL251024 94416 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
23649184 190336 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5176593 190336 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
1776 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5006 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
9854012 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL334966 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
DB06441 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
44443921 168754 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL437204 168754 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
1776 787 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
5006 787 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
9854012 787 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
CHEMBL334966 787 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
DB06441 787 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
44555026 111942 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111942 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11526078 91307 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 91307 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68910943 92101 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 92101 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
44443917 94382 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250832 94382 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
24751997 62828 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62828 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68550683 191057 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5187308 191057 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
45485968 197747 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 197747 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752128 62803 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62803 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269461 196194 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 196194 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752129 62810 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62810 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457371 10362 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
CHEMBL1162189 10362 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
10098947 10340 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162163 10340 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
11786496 10351 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162176 10351 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
53233471 62837 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62837 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911088 91281 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 91281 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11504760 91291 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 91291 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
53233471 62837 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62837 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62824 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62824 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485965 196772 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 196772 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 197522 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 197522 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 194888 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 194888 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751300 62812 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62812 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62824 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62824 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751575 62827 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62827 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62845 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62845 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650877 201199 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60353 201199 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45272846 195654 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 195654 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801416 10375 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162205 10375 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
45268630 196088 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 196088 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457278 10344 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162167 10344 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
45485930 197194 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 197194 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485858 197322 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 197322 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 197547 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 197547 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751438 62802 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62802 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15650865 100781 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292978 100781 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650880 101036 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL294588 101036 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650878 201218 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60362 201218 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452737 96891 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL265707 96891 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457411 10368 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162197 10368 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
16739157 10353 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162179 10353 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
44610522 111933 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288125 111933 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11712235 91321 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 91321 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11620159 92102 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 92102 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
68916097 91293 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 91293 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
45485943 197117 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 197117 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485960 197126 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 197126 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 197443 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 197443 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 197449 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 197449 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485900 197517 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 197517 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752269 62801 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62801 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
131257 202771 6 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62094 202771 6 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452879 161289 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL412171 161289 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45269473 196340 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 196340 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485896 196779 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 196779 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485934 196976 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 196976 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485941 197021 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 197021 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751996 62850 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62850 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650899 202967 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
CHEMBL63016 202967 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
71740705 91294 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 91294 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45270300 195397 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 195397 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650869 203139 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64144 203139 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650870 203142 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64149 203142 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45270321 195519 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 195519 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
11706300 91288 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 91288 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 91319 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 91319 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45485969 196767 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 196767 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485902 197425 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 197425 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 197555 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 197555 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 197568 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 197568 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752560 62804 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62804 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485853 197353 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 197353 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269438 196001 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 196001 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24968874 92099 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 92099 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
11273179 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
1770 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
CHEMBL1162175 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
DB05553 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
11273179 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
1770 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
CHEMBL1162175 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
DB05553 3301 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
90644282 111930 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111930 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
16739124 10361 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162188 10361 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485966 196843 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 196843 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 197494 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 197494 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485952 197553 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 197553 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271155 195640 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 195640 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751579 62819 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62819 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457276 10343 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162166 10343 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
44457392 10365 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
CHEMBL1162194 10365 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
44610468 111935 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111935 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
54586076 62554 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62554 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
73345971 91299 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 91299 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
45485937 197247 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 197247 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485859 197460 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 197460 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751581 62518 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62518 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54586076 62554 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62554 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45269484 195665 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 195665 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45271145 194929 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 194929 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
69224603 92086 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 92086 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
15983052 92087 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 92087 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
24752130 62806 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62806 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62838 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62838 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
71740819 91295 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 91295 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485857 197477 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 197477 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485938 197526 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 197526 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 194849 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 194849 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54585885 62830 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62830 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457274 10342 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162165 10342 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
44554515 111931 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
69224555 92092 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 92092 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68556549 111929 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111929 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11503160 91313 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 91313 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
24752131 62841 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62841 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269454 196118 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 196118 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 196674 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 196674 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650861 202691 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61623 202691 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15983175 92091 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 92091 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
45485945 197078 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 197078 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485947 197546 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 197546 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272055 194893 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 194893 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751995 62818 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62818 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751708 62846 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62846 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650881 203143 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64153 203143 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453107 155307 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403010 155307 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272035 195089 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 195089 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11570029 91306 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 91306 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
16739091 10349 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162172 10349 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
24752557 62805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485916 196901 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 196901 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
54584960 62854 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62854 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272842 195624 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 195624 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739125 10350 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162173 10350 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
68916926 139691 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139691 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
11684912 91301 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 91301 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11561528 91323 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 91323 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68842714 91324 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 91324 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485911 197508 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 197508 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751572 62555 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62555 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
44453110 155308 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403011 155308 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
15983053 92090 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 92090 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
69224054 92097 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 92097 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
45485961 197005 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 197005 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750723 62813 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62813 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485954 197554 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 197554 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270322 194782 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 194782 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24750719 62853 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62853 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24799317 10337 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162160 10337 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
16739092 10348 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162171 10348 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
44457422 10371 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
CHEMBL1162200 10371 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
68918061 91282 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 91282 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11699088 91287 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 91287 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752711 62834 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62834 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45271154 195670 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 195670 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25022501 95082 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255349 95082 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452925 166424 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL427723 166424 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452982 95123 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255553 95123 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
23649325 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68911289 91311 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 91311 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 91311 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
23649325 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 541 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
11993787 92098 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 92098 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
44452926 97417 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL269934 97417 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273798 195688 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 195688 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913927 91318 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 91318 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11532836 91328 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 91328 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68554177 191281 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5190691 191281 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
24751574 62553 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62553 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751999 62817 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62817 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485892 197035 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 197035 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 197218 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 197218 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485848 197387 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 197387 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485890 197483 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 197483 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485967 197545 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 197545 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751574 62553 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62553 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
24751999 62817 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62817 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650866 201324 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60422 201324 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45273812 195756 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 195756 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44610518 111932 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288124 111932 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
90644279 111941 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
CHEMBL3288133 111941 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
45485963 197092 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 197092 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752561 62831 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62831 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752421 62840 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62840 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44452951 97754 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL271643 97754 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485939 197150 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 197150 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 197744 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 197744 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457290 10345 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162168 10345 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485959 197209 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 197209 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
23642329 62820 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62820 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270323 195247 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 195247 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650882 202945 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62928 202945 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271984 195088 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 195088 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273789 195907 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 195907 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45267750 195927 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 195927 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739158 10341 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162164 10341 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
15983055 92088 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 92088 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
54580044 62855 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62855 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44453131 155463 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403928 155463 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
11503687 91329 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 91329 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
2746550 62809 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62809 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485919 196790 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 196790 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485852 197424 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 197424 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485861 197464 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 197464 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485909 197513 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 197513 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270295 194771 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 194771 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579996 62825 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62825 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62844 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62844 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650875 203208 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64383 203208 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742794 203295 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64734 203295 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457324 10352 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162178 10352 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
11561748 92100 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 92100 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
45268594 195563 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 195563 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801573 10366 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162195 10366 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
24752422 62808 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62808 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11641496 91286 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 91286 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68911008 91317 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 91317 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15983546 92105 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 92105 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
24752271 62832 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62832 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10335 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10335 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45273819 195153 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 195153 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270314 195145 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 195145 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11569565 91320 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 91320 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
1746 2042 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
44457307 2042 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
CHEMBL1162174 2042 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
24752270 62833 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62833 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485888 196961 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 196961 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44304081 165719 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
CHEMBL424596 165719 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
16739093 10355 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
CHEMBL1162182 10355 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
23649325 541 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
7360 541 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
CHEMBL2419490 541 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
45485862 197478 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 197478 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485905 197521 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 197521 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269465 196254 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 196254 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11677907 91283 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 91283 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
45485956 197566 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 197566 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740352 91325 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 91325 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485894 197453 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 197453 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54580995 62816 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62816 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983672 92095 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 92095 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
11663657 91302 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 91302 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11656053 91309 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 91309 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68914580 91312 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 91312 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751712 62829 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62829 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44452947 155187 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402401 155187 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485863 197465 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 197465 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270294 195328 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 195328 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54584163 62556 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62556 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
11519648 91300 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 91300 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
1765 3817 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
4184 3817 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
9871419 3817 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
CHEMBL398435 3817 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
DB08816 3817 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
45485962 197029 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 197029 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 194849 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 194849 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 196100 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 196100 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44452898 95083 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255350 95083 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485935 197050 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 197050 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 197567 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 197567 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273782 195508 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 195508 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650862 201429 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60481 201429 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650876 202376 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61062 202376 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742793 202948 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62939 202948 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650873 203394 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL65466 203394 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650872 203549 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66594 203549 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11595497 203147 6 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64162 203147 6 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
16739094 10357 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162184 10357 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485889 196988 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 196988 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268642 195618 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 195618 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650856 101024 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL294535 101024 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650888 203558 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
CHEMBL66647 203558 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
44610519 111934 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111934 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
24751850 62821 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62821 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272861 195481 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 195481 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650874 203473 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66027 203473 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650867 102289 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
CHEMBL303366 102289 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
15650864 201319 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60420 201319 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453009 155216 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402592 155216 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485851 197432 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 197432 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272036 195586 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 195586 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650858 200596 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59922 200596 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
24752419 62835 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62835 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751576 62849 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62849 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270296 195329 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 195329 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24799834 10363 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162190 10363 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
122192512 123809 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
CHEMBL3623467 123809 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
24751710 62847 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62847 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583974 62826 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62826 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457292 10346 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162169 10346 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
11497605 91303 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 91303 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11691323 91310 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 91310 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650857 200429 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
CHEMBL59822 200429 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
44452736 96165 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL260602 96165 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457401 10367 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162196 10367 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
44453109 155255 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402800 155255 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485957 197557 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 197557 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 197745 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 197745 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750874 62842 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62842 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
45485864 196986 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 196986 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453032 97843 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272113 97843 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
54579997 62848 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62848 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650871 203323 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64863 203323 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
24752558 91296 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 91296 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45485915 197523 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 197523 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 197514 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 197514 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453132 98025 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272975 98025 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24801414 10338 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162161 10338 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485901 197520 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 197520 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457251 10336 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162159 10336 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
16739123 10358 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162185 10358 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
11627571 91290 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 91290 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485908 197512 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 197512 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740353 91326 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 91326 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485942 197527 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 197527 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650887 203246 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
CHEMBL64555 203246 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
15982393 91322 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 91322 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45272869 195482 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 195482 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579995 62811 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62811 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10335 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10335 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45485932 197158 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 197158 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267721 196722 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 196722 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44608149 111937 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111937 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68911155 91316 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 91316 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24799835 10360 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162187 10360 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45272054 194892 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 194892 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
69224988 92096 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 92096 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
68911027 91285 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 91285 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
44452952 155068 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL401780 155068 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24750561 62851 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62851 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
45267728 196206 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 196206 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650859 102205 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL302875 102205 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68556579 111936 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111936 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
15650886 100637 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292047 100637 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
44452878 97077 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL267283 97077 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273811 196497 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 196497 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485933 197525 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 197525 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271092 196444 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 196444 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485886 197482 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 197482 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485950 197549 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 197549 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750876 62839 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62839 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45273818 194848 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 194848 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580993 62799 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62799 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15983670 92089 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 92089 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
45485903 197518 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 197518 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650860 202845 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62470 202845 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457294 10347 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
CHEMBL1162170 10347 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
45485914 197515 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 197515 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44452921 95263 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL256251 95263 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
2746549 62552 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62552 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
2746549 62552 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62552 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485946 197775 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 197775 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
68913220 91284 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 91284 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
45485953 197565 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 197565 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650898 202850 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62500 202850 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11569565 91320 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 91320 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
24751577 62843 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62843 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485856 197474 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 197474 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650868 200573 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59911 200573 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68911120 92094 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 92094 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
45272902 195715 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 195715 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485898 197176 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 197176 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
73294137 92093 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 92093 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
45485922 197068 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 197068 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267707 195969 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 195969 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 195272 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 195272 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457338 10354 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
CHEMBL1162181 10354 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
25165435 111940 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111940 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
54581027 62852 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62852 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269483 194793 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 194793 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272881 194861 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 194861 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 196355 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 196355 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 195310 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 195310 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485921 197018 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 197018 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 197524 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 197524 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273820 194850 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 194850 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913141 91314 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 91314 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
45485918 196974 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 196974 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269472 196339 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 196339 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485849 197429 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 197429 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
90644280 111939 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111939 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
68911205 92103 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 92103 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
15650883 163273 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL418660 163273 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44241562 196432 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
CHEMBL562982 196432 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
45485936 197054 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 197054 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 197139 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 197139 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829943 195914 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 195914 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268619 195506 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 195506 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15983301 91315 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 91315 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
44457262 10339 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162162 10339 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
24750557 62814 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62814 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11697626 92104 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 92104 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
24751851 62823 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62823 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
4742792 200628 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL59941 200628 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271128 194928 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 194928 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580185 62559 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62559 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485931 196865 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 196865 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54585098 62558 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62558 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457247 10334 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10334 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485855 197473 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 197473 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485917 197498 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 197498 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457247 10334 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10334 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
11627317 91292 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 91292 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650897 200815 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60083 200815 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11706351 91304 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 91304 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45142449 196330 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 196330 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650863 201031 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60240 201031 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
90644281 111938 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111938 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
45485958 197123 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 197123 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 197519 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 197519 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485860 197461 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 197461 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268641 194838 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 194838 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752559 62807 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62807 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751297 62815 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62815 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62822 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62822 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11699570 91305 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 91305 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
54580994 62800 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62800 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24829780 196465 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 196465 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68910943 92101 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 92101 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11684524 91308 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 91308 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751017 91327 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 91327 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
44452977 95561 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL257651 95561 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272880 195483 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 195483 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44583582 3204 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
5904 3204 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
59448166 3204 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL1207916 3204 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL455536 3204 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
44583582 3204 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
5904 3204 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
59448166 3204 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL1207916 3204 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL455536 3204 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
1765 3817 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3817 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3817 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3817 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3817 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1776 787 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
5006 787 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
9854012 787 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
CHEMBL334966 787 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
DB06441 787 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
10340 1120 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
137553172 1120 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
1764 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
189762 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
CHEMBL606240 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
1732 450 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
25243905 450 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
16741348 757 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
1766 757 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
139031067 1112 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
6148 1112 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
73755176 1112 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
3384 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
3384 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
5311009 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
5311009 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
CHEMBL1160359 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
CHEMBL1160359 473 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
1776 787 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
5006 787 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
9854012 787 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
CHEMBL334966 787 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
DB06441 787 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
121990 75 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1710 75 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1763 75 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
CHEMBL435402 75 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1755 289 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
5310996 289 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
CHEMBL335206 289 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
1776 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
5006 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
9854012 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
CHEMBL334966 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
DB06441 787 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
10405534 3268 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1771 3268 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
CHEMBL3526431 3268 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1769 2043 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
91827342 2043 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
16681707 759 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
1767 759 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
CHEMBL2172275 759 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
11273179 3301 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1770 3301 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
CHEMBL1162175 3301 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
DB05553 3301 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1765 3817 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
4184 3817 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
9871419 3817 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
CHEMBL398435 3817 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
DB08816 3817 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

44443919 94416 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL251024 94416 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
1776 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5006 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
9854012 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL334966 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
DB06441 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
1776 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
5006 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
9854012 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
CHEMBL334966 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
DB06441 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
1776 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
5006 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
9854012 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
CHEMBL334966 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
DB06441 787 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
44443921 168754 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL437204 168754 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
10557443 10225 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
CHEMBL1160364 10225 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
66575818 114069 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 114069 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111931 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
49764561 190136 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5173489 190136 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
49764180 190537 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5179719 190537 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
46931928 190835 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5184268 190835 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763085 191434 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5192953 191434 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
49764183 191591 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5195237 191591 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763087 192115 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5203416 192115 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
15983053 92090 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 92090 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
66854978 191282 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5190693 191282 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
87180479 192360 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207212 192360 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
1765 3817 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
4184 3817 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
9871419 3817 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
CHEMBL398435 3817 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
DB08816 3817 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
44443917 94382 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL250832 94382 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
118711090 113851 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113851 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67460312 113621 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322621 113621 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711072 113833 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113833 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711074 113835 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113835 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711077 113838 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113838 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711079 113840 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113840 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711087 113848 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113848 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711091 113852 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113852 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576450 113895 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113895 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54581027 62852 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62852 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580044 62855 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62855 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600063 126662 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
CHEMBL3652613 126662 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
118711172 113893 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113893 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127039360 137141 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
127040666 137141 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745863 137141 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747870 137141 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
25165435 111940 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111940 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
44608149 111937 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111937 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711093 113854 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113854 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 541 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 541 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 541 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24968874 92099 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 92099 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
118711190 113917 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113917 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113918 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113918 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113919 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113919 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
67460624 113633 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322632 113633 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607689 104212 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 104212 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983055 92088 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 92088 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
24751997 62828 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62828 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL54256 194948 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 664 7 2 14 1.5 CS(=O)(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(S(C)(=O)=O)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711084 113845 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113845 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711086 113847 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113847 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711088 113849 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113849 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113898 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113898 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113905 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113905 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
11684524 91308 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 91308 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11561528 91323 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 91323 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752129 62810 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62810 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751577 62843 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62843 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968628 165130 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227647 165130 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145971167 165152 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4227969 165152 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
145967502 165189 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228684 165189 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
44610519 111934 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111934 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68556579 111936 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111936 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711089 113850 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113850 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127038951 137150 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240906 137150 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746312 137150 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747879 137150 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
71607634 104205 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 104205 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711083 113844 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113844 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
90644280 111939 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111939 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
118711091 113852 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113852 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113909 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113909 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
68600322 126660 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652611 126660 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
15983175 92091 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 92091 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
118711180 113902 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113902 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11684912 91301 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 91301 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706351 91304 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 91304 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911120 92094 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 92094 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
118711179 113901 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113901 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983175 92091 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 92091 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
24751575 62827 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62827 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
22185065 165078 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226930 165078 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71740352 91325 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 91325 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711096 113857 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113857 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
67463039 113614 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322614 113614 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711074 113835 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113835 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607553 104206 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 104206 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44554515 111931 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
2741913 114063 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 114063 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
67460741 113631 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322630 113631 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
16681707 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
1767 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
CHEMBL2172275 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
16681707 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 759 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
66575821 113942 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113942 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
24752558 91296 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 91296 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
118711969 114064 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 114064 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
25175044 126652 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
CHEMBL3652603 126652 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
24985991 191776 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
CHEMBL5197988 191776 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
127041005 137146 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240702 137146 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746901 137146 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747875 137146 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
118711185 113910 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113910 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
71607634 104205 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 104205 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711077 113838 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113838 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 541 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
127040347 137139 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241743 137139 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747704 137139 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747869 137139 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
11504760 91291 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 91291 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11712235 91321 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 91321 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
44610468 111935 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111935 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711090 113851 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113851 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711092 113853 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113853 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
46241019 137135 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745979 137135 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747865 137135 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751999 62817 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62817 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751999 62817 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62817 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751995 62818 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62818 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968144 165098 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227196 165098 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113912 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113912 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
12000767 113607 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322597 113607 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711193 113922 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113922 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
71264539 104213 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098249 104213 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983672 92095 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 92095 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
118711177 113899 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113899 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113916 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113916 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118710245 113651 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113651 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
74220534 113943 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113943 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
11532836 91328 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 91328 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987950 165211 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228996 165211 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711071 113832 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113832 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711249 113948 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113948 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
145970219 165125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227595 165125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145969360 165195 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228736 165195 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
118711064 113826 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113826 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607662 104203 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098236 104203 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44762396 114062 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 114062 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
59534140 113643 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322642 113643 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11706351 91304 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 91304 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
71607589 104201 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 104201 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11993787 92098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 92098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
24751708 62846 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62846 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711064 113826 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113826 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463112 113611 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322611 113611 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
71607592 104204 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 104204 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
71607664 104209 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098243 104209 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
44762396 114062 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 114062 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
67460401 113615 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322615 113615 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68600802 126655 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652606 126655 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
15983546 92105 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 92105 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
66575899 113941 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113941 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
118711970 114065 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326903 114065 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
66575899 113941 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
CHEMBL3325891 113941 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
44296486 188941 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL50806 188941 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL540200 194869 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
CHEMBL540200 194869 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1021/acs.jmedchem.5b01972
11684912 91301 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 91301 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
23642329 62820 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62820 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711075 113836 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113836 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711098 113860 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113860 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113909 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113909 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
24752560 62804 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62804 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62822 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62822 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62845 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62845 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145967823 164957 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4225138 164957 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
71607553 104206 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 104206 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67462688 113613 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322613 113613 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12002005 113624 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322624 113624 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
1776 787 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
5006 787 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
9854012 787 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
CHEMBL334966 787 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
DB06441 787 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
11561528 91323 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 91323 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL300240 101817 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 652 9 2 14 3.0 CCOC(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C(=O)OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711076 113837 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113837 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66575818 114069 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 114069 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
69224555 92092 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 92092 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
24751572 62555 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62555 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
24752269 62801 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62801 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752559 62807 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62807 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
10292521 164975 6 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225415 164975 6 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
22184925 165144 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
CHEMBL4227910 165144 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
6918456 14515 110 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
CHEMBL1201772 14515 110 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
118711973 114068 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 114068 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145970653 165093 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227170 165093 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607633 104202 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098235 104202 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11569565 91320 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 91320 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711174 113896 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113896 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113897 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113897 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11503160 91313 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 91313 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11503687 91329 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 91329 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913927 91318 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 91318 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24750723 62813 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62813 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750557 62814 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62814 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145967657 165063 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226648 165063 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
24752128 62803 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62803 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750719 62853 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62853 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145970872 165068 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226722 165068 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
15983670 92089 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 92089 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
118711073 113834 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113834 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607666 104211 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 104211 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67459391 113616 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322616 113616 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24786234 139747 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139747 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1776 787 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
5006 787 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
9854012 787 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
CHEMBL334966 787 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
DB06441 787 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
24786234 139747 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139747 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1756 463 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5310954 463 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL336292 463 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
87416471 191669 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5196387 191669 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
73603967 113944 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113944 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
15982393 91322 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 91322 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576297 113859 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113859 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711190 113917 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113917 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113919 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113919 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11620159 92102 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 92102 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
11697626 92104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 92104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
145970444 165148 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227949 165148 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711185 113910 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113910 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
90644282 111930 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111930 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711972 114067 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 114067 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67462328 113619 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322619 113619 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461716 113628 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322628 113628 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001755 113642 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322641 113642 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68913927 91318 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 91318 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
127039361 137142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
127039919 137142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746192 137142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747871 137142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11699088 91287 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 91287 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752130 62806 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62806 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145969883 164942 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4224920 164942 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
54697995 194724 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL53491 194724 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
145986354 165236 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229217 165236 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
12002012 113647 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322646 113647 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67464394 113623 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322623 113623 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
23649325 541 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
66576377 113903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
71607631 104207 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 104207 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
127039316 137138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46196450 137138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747385 137138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747868 137138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
69223141 92085 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419480 92085 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
118711067 113830 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113830 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
44296002 14787 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206713 14787 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299307 14787 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
168274164 190409 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5177774 190409 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL301991 102056 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 536 5 2 10 3.3 Cc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
145969318 165136 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227756 165136 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
67463698 113637 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322636 113637 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111931 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118710244 113650 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322649 113650 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11570029 91306 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 91306 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
73294137 92093 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 92093 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
118711183 113908 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113908 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
24751438 62802 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62802 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751300 62812 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62812 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11451 3211 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
132574707 3211 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
CHEMBL4116316 3211 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
118711972 114067 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 114067 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911027 91285 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 91285 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
24751850 62821 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62821 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983546 92105 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 92105 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
127040000 137136 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241331 137136 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746558 137136 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747866 137136 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
73345971 91299 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 91299 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
24751017 91327 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 91327 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751581 62518 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62518 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54580185 62559 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62559 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
60606 61560 73 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
CHEMBL1771 61560 73 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
137630000 161030 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4087247 161030 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116405 161030 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
67460268 113644 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322643 113644 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627571 91290 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 91290 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145970953 165177 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228415 165177 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711972 114067 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 114067 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67461519 113618 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322618 113618 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 91316 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 91316 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576450 113895 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113895 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11526078 91307 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 91307 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987961 165240 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229257 165240 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711249 113948 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113948 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
12000848 113608 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322598 113608 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 91316 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 91316 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576298 113820 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113820 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711102 113865 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113865 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459575 113622 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322622 113622 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
145971125 165077 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226913 165077 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113912 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113912 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
24968874 92099 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 92099 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
54580993 62799 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62799 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580995 62816 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62816 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62844 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62844 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711065 113827 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
CHEMBL3325626 113827 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
66575821 113942 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113942 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
67464143 113617 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322617 113617 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461890 113636 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322635 113636 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68598655 126658 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652609 126658 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711173 113894 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113894 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607589 104201 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 104201 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983053 92090 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 92090 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
68556549 111929 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111929 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711098 113860 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113860 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
16681707 759 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 759 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 759 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
71607631 104207 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 104207 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
15983672 92095 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 92095 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
69224054 92097 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 92097 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
68913220 91284 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 91284 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
118710243 113646 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322645 113646 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
137630586 161087 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4081274 161087 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116838 161087 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
25022583 126665 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
CHEMBL3652616 126665 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
25022583 126665 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
CHEMBL3652616 126665 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
59534139 113653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322652 113653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44464779 113654 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113654 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
42629406 191170 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5188874 191170 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
69224988 92096 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 92096 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
25110832 189963 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5170672 189963 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
66576297 113859 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113859 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576451 113904 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113904 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113918 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113918 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120573 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120573 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120573 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113916 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113916 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711190 113917 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113917 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11503687 91329 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 91329 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711974 114070 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326908 114070 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 91281 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 91281 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11677907 91283 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 91283 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
118711067 113830 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113830 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120574 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120574 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120574 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001296 113632 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322631 113632 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
46241233 137137 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746620 137137 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747867 137137 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
2746550 62809 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62809 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
127040676 137143 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240598 137143 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746188 137143 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747872 137143 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751297 62815 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62815 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
22916 14725 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL1206272 14725 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL256057 14725 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
71607687 104215 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098251 104215 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983670 92089 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 92089 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
11547134 192527 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
CHEMBL5209548 192527 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
2746549 62552 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62552 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62838 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62838 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3817 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
4184 3817 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
9871419 3817 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
CHEMBL398435 3817 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
DB08816 3817 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
23649325 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
23649325 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 541 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24751579 62819 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62819 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15982393 91322 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 91322 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711094 113855 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113855 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607689 104212 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 104212 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
2746549 62552 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62552 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24752131 62841 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62841 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113945 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113945 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113907 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113907 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
168293684 192192 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5204363 192192 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
127040999 137145 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240799 137145 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746598 137145 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747874 137145 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
12001662 113649 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322648 113649 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607632 104208 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 104208 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113829 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113829 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54732977 101777 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL299983 101777 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
54732982 101886 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL300750 101886 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL5288399 194422 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 572 10 4 4 7.0 O=C(CCCCCCCC(=O)Nc1ccc2[nH]c3ccccc3c(=O)c2c1)Nc1ccc2[nH]c3ccccc3c(=O)c2c1 10.1039/d2md00285j
137630492 161077 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4090874 161077 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4116755 161077 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
67460935 113627 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322627 113627 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11691323 91310 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 91310 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711186 113911 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113911 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
54732979 188406 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL50192 188406 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
66919972 190082 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5172707 190082 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
11519648 91300 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 91300 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24751712 62829 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62829 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68916097 91293 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 91293 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
68911205 92103 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 92103 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
68911205 92103 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 92103 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
66576448 120573 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120573 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120573 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
118710245 113651 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113651 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68597944 126663 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652614 126663 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68601276 126668 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652619 126668 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
44554515 111931 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
44464779 113654 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113654 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11569565 91320 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 91320 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL540200 194869 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Compound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyteCompound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyte
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
74220534 113943 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113943 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
67462098 113648 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322647 113648 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66576298 113820 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113820 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711083 113844 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113844 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711093 113854 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113854 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711097 113858 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113858 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711101 113863 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113863 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711102 113865 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113865 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711172 113893 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113893 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711174 113896 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113896 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711180 113902 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113902 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113905 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113905 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576610 113906 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113906 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
66576296 113916 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113916 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576221 113946 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113946 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
66575819 113828 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113828 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113903 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113903 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
118711191 113918 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113918 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711073 113834 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113834 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711973 114068 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 114068 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111931 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711097 113858 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113858 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607665 104214 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 104214 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113829 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113829 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54584163 62556 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62556 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
1765 3817 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
4184 3817 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
9871419 3817 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
CHEMBL398435 3817 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
DB08816 3817 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
11569565 91320 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 91320 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
68916097 91293 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 91293 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL5279963 194044 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 597 9 3 10 4.6 CCOC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4c(-c5ccccc5)noc4C)cn3C)cn2C)cn1C 10.1039/d2md00285j
12001028 113529 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3321766 113529 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118710246 113652 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322651 113652 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11663657 91302 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 91302 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68914580 91312 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 91312 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24750876 62839 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62839 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145970029 165174 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4228398 165174 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
23649325 541 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118711099 113861 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113861 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983301 91315 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 91315 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68916926 139691 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139691 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
2741913 114063 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 114063 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
145967859 165012 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4225935 165012 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
118711086 113847 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113847 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113864 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113864 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118710241 113620 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322620 113620 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67459247 113641 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322640 113641 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66575819 113828 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113828 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
54579997 62848 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62848 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711078 113839 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113839 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711971 114066 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
CHEMBL3326904 114066 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
53233471 62837 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62837 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
53233471 62837 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62837 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
66576451 113904 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113904 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711181 113905 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113905 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576221 113946 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113946 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
71607632 104208 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 104208 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11561748 92100 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 92100 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
44296000 14791 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206719 14791 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299895 14791 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
24752421 62840 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62840 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113945 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113945 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
168283736 192903 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5183695 192903 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5222086 192903 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
68911008 91317 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 91317 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
71607665 104214 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 104214 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
24752557 62805 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62805 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598694 126661 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652612 126661 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
68599106 126664 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652615 126664 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68599934 126666 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
CHEMBL3652617 126666 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
1765 3817 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
4184 3817 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
9871419 3817 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
CHEMBL398435 3817 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
DB08816 3817 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
66575819 113828 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113828 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
127047545 139576 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139576 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
66576610 113906 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113906 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
16066663 78148 38 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
CHEMBL2103828 78148 38 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
118711085 113846 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113846 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711089 113850 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113850 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113897 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113897 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711177 113899 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113899 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711178 113900 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113900 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113903 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113903 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
66576375 120574 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120574 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120574 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576298 113820 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113820 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576451 113904 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113904 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113907 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113907 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113920 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120574 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120574 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120574 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
1765 3817 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
4184 3817 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
9871419 3817 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
CHEMBL398435 3817 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
DB08816 3817 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
11561748 92100 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 92100 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
24752271 62832 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62832 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752270 62833 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62833 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3817 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
4184 3817 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
9871419 3817 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
CHEMBL398435 3817 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
DB08816 3817 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
67460979 113626 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322626 113626 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67463220 113640 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322639 113640 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11656053 91309 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 91309 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184858 164999 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4225733 164999 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
12001567 113629 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322629 113629 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001030 113635 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322634 113635 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711188 113913 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325799 113913 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
54583974 62826 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62826 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711250 113949 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113949 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
67462183 113638 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322637 113638 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627317 91292 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 91292 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54584960 62854 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62854 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54585885 62830 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62830 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711194 113923 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113923 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
24752561 62831 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62831 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68910943 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
67462816 113625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322625 113625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24750874 62842 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62842 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
118711189 113915 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325800 113915 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
69224555 92092 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 92092 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68911289 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL2402255 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL5206028 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
68911289 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 91311 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
66575899 113941 3 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113941 3 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
68910943 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
137630841 161113 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4069492 161113 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4117118 161113 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
118711081 113842 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113842 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711182 113907 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113907 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113921 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113921 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
24751998 62824 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62824 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751851 62823 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62823 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751998 62824 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62824 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711070 113831 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113831 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711075 113836 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113836 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11949423 192375 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207480 192375 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
24750561 62851 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62851 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
11503160 91313 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 91313 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68918061 91282 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 91282 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
71607663 104210 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098244 104210 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11677907 91283 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 91283 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
46233355 200549 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL598998 200549 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111931 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111931 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL5280208 194057 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 502 5 4 4 5.0 O=C(CCC(=O)Nc1ccc2[nH]c3ccccc3c(=O)c2c1)Nc1ccc2[nH]c3ccccc3c(=O)c2c1 10.1039/d2md00285j
68601482 126654 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
CHEMBL3652605 126654 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
118711087 113848 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113848 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607592 104204 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 104204 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11641496 91286 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 91286 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711095 113856 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113856 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113898 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113898 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71740819 91295 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 91295 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579996 62825 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62825 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600085 126653 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
CHEMBL3652604 126653 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
15983052 92087 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 92087 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
68910943 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 92101 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11699570 91305 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 91305 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68842714 91324 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 91324 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579995 62811 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62811 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11497605 91303 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 91303 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
10294407 165108 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227347 165108 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
69224054 92097 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 92097 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
66576220 113920 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
73603967 113944 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113944 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
118711973 114068 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 114068 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711179 113901 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113901 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711094 113855 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113855 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711100 113862 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113862 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113864 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113864 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711193 113922 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113922 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576610 113906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
44555026 111942 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111942 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68600647 126657 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652608 126657 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711079 113840 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113840 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113843 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113843 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24937181 197449 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL569732 197449 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
118711088 113849 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113849 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001479 113634 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322633 113634 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
127038949 137149 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46241636 137149 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746852 137149 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747878 137149 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11620159 92102 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 92102 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
118711248 113947 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113947 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
24752419 62835 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62835 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711100 113862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711183 113908 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113908 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
118710242 113645 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322644 113645 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24752422 62808 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62808 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44296487 102034 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
CHEMBL301805 102034 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
24751576 62849 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62849 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11519648 91300 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 91300 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
15983301 91315 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 91315 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
145969559 165154 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228020 165154 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
68599474 126667 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652618 126667 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
66576220 113920 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113920 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
127047545 139576 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139576 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
127047545 139576 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1021/acs.jmedchem.5b01972
CHEMBL3797316 139576 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1021/acs.jmedchem.5b01972
118711969 114064 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 114064 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL53599 194740 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 568 7 2 12 2.7 COc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711070 113831 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113831 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711078 113839 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113839 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113843 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113843 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711099 113861 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113861 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711173 113894 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113894 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711067 113830 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113830 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
11699570 91305 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 91305 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
90644281 111938 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111938 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
118711194 113923 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113923 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
118711101 113863 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113863 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24752711 62834 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62834 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598525 126656 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652607 126656 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711064 113826 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113826 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711080 113841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
22184814 164972 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225388 164972 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607666 104211 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 104211 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
68913141 91314 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 91314 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711178 113900 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113900 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145967492 165179 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228420 165179 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145986356 165237 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229219 165237 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
145970199 165089 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227070 165089 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711085 113846 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113846 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11684524 91308 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 91308 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 91319 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 91319 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711076 113837 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113837 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62554 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62554 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
69224603 92086 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 92086 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
118711092 113853 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113853 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62554 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62554 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184796 165172 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4228342 165172 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
23649325 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68598844 126659 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
CHEMBL3652610 126659 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
23649325 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 541 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118710247 113655 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322654 113655 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911289 91311 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 91311 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 91311 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11526078 91307 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 91307 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711080 113841 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113841 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711095 113856 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113856 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711096 113857 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113857 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
69224988 92096 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 92096 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
22185105 165137 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4227774 165137 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
118711072 113833 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113833 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24751574 62553 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62553 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751574 62553 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62553 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
118711066 113829 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113829 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711250 113949 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113949 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
127040997 137144 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240803 137144 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746502 137144 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747873 137144 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
71740705 91294 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 91294 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913141 91314 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 91314 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711071 113832 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113832 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711084 113845 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113845 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 91281 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 91281 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706300 91288 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 91288 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711081 113842 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113842 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459556 113612 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322612 113612 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751996 62850 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62850 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711248 113947 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113947 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
54580994 62800 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62800 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
12000684 113639 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322638 113639 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751710 62847 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62847 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
66575818 114069 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 114069 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463976 113609 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322599 113609 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
54585098 62558 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62558 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711186 113911 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113911 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
71740353 91326 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 91326 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
1756 463 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
5310954 463 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
CHEMBL336292 463 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
168296904 192990 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5199350 192990 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5222620 192990 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
20690446 94419 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL251041 94419 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
58334279 190664 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5181634 190664 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
45485957 197557 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 197557 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485932 197158 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 197158 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485963 197092 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 197092 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232890 200931 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601696 200931 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485958 197123 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 197123 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485931 196865 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 196865 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44443939 94206 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249790 94206 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
46232949 200901 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601489 200901 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485966 196843 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 196843 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485957 197557 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL570295 197557 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485898 197176 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 197176 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485962 197029 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 197029 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485943 197117 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 197117 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485959 197209 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 197209 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232887 200930 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601695 200930 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44129060 82325 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172149 82325 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485961 197005 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 197005 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485965 196772 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 196772 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485968 197747 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 197747 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232894 200933 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601698 200933 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485952 197553 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 197553 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485886 197482 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 197482 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141136 197360 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL569097 197360 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 200927 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601692 200927 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 200927 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601692 200927 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232896 200964 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601903 200964 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485889 196988 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 196988 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485922 197068 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 197068 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 197218 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 197218 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485849 197429 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 197429 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485850 197431 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569680 197431 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 197519 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 197519 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232899 200966 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601905 200966 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485917 197498 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 197498 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 197555 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 197555 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139405 199374 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590950 199374 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139408 200778 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600575 200778 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485938 197526 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 197526 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233241 198541 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578094 198541 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233234 199486 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591712 199486 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232943 200897 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601485 200897 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485915 197523 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 197523 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 197567 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 197567 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44129137 82306 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172129 82306 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233325 198589 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578522 198589 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 199172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589519 199172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140552 199633 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592850 199633 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141342 200894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601478 200894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 199172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589519 199172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232879 199204 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589804 199204 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141342 200894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601478 200894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
20690429 97038 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL266922 97038 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485969 196767 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 196767 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485914 197515 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 197515 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140751 199356 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590749 199356 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233243 199562 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592410 199562 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140554 199564 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592441 199564 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232911 199241 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590008 199241 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232950 199262 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590146 199262 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232942 199277 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590260 199277 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232940 200895 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601483 200895 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140553 199639 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592883 199639 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233242 198585 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578507 198585 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 199145 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589335 199145 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 199145 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589335 199145 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
1765 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
4184 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
9871419 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
CHEMBL398435 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
DB08816 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
44443935 153875 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398295 153875 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485944 196797 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565573 196797 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 196953 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 196953 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272861 195481 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 195481 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270323 195247 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551020 195247 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141135 198539 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578076 198539 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139404 199597 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592650 199597 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139592 200418 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598161 200418 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142222 200753 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600370 200753 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141980 201131 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603145 201131 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232921 199271 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590254 199271 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232930 200862 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601274 200862 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485950 197549 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 197549 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
21130371 14887 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1207842 14887 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL445413 14887 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
106250 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
106250 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208092 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208092 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496030 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496030 14916 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25125169 14917 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208096 14917 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496229 14917 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123834 14945 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208284 14945 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522725 14945 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
3018777 60250 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1671995 60250 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1741070 60250 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
44129368 82361 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172270 82361 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129451 82316 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172139 82316 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485887 196926 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566309 196926 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 197139 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 197139 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485930 197194 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 197194 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 197443 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 197443 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 197449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 197449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485856 197474 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 197474 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271154 195670 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 195670 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45269438 196001 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 196001 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271154 195670 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556522 195670 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269438 196001 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560009 196001 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233330 198485 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577630 198485 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142218 199196 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589719 199196 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139770 199198 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589737 199198 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140934 199512 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591991 199512 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233240 199561 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592409 199561 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139585 199581 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592535 199581 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139767 199637 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592881 199637 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139951 200215 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596750 200215 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140164 201137 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603151 201137 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232882 199234 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590001 199234 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232927 200860 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601272 200860 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855175 82315 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172138 82315 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45140745 200632 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599422 200632 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24829943 195914 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 195914 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24829943 195914 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559259 195914 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45267707 195969 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 195969 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233356 200550 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598999 200550 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485848 197387 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 197387 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485863 197465 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 197465 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 197514 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 197514 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485946 197775 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 197775 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 194888 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 194888 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267751 194888 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540672 194888 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141347 198542 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578102 198542 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139407 199128 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589216 199128 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140754 199371 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590874 199371 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141343 200449 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598387 200449 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232920 200887 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601447 200887 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232884 200928 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601693 200928 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232895 200934 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601699 200934 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142448 201682 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL606209 201682 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
11950159 197115 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 197115 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16120270 14944 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208282 14944 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522053 14944 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485864 196986 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 196986 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
3711684 14947 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208290 14947 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524284 14947 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45139955 201132 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603146 201132 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232904 199186 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589597 199186 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232933 199275 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590258 199275 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487796 196955 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566447 196955 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
66854575 82321 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172145 82321 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
46233389 200450 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL598388 200450 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233222 200304 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597380 200304 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44126037 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
5905 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
CHEMBL2172277 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
45485907 197506 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570020 197506 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273819 195153 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 195153 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268593 196612 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564150 196612 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
1765 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
4184 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
9871419 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
CHEMBL398435 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
DB08816 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
45273819 195153 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL550278 195153 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268593 196612 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564150 196612 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140361 199474 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591619 199474 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487821 197118 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 197118 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45267728 196206 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561484 196206 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233388 199176 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL589528 199176 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233630 200554 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599006 200554 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273798 195688 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 195688 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270318 195168 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550415 195168 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485861 197464 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 197464 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 195310 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 195310 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268642 195618 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 195618 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 194850 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539734 194850 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141581 199207 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589817 199207 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140155 200624 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
CHEMBL599399 200624 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
24829442 201253 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603866 201253 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631970 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539733 194849 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45273820 194850 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539734 194850 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232902 199142 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589298 199142 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45270274 195758 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
CHEMBL557553 195758 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
13991590 157366 49 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL4077922 157366 49 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45269482 194792 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538644 194792 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 196355 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 196355 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 196355 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562485 196355 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485858 197322 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 197322 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232923 199244 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590039 199244 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232916 200998 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602110 200998 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487809 196952 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 196952 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45271977 195022 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549307 195022 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233386 200591 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599202 200591 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487841 196803 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 196803 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45485882 197480 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569912 197480 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141770 199349 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590742 199349 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232931 199249 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590087 199249 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25863 60262 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1672104 60262 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1741102 60262 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
11950328 197278 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 197278 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856100 82312 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
CHEMBL2172135 82312 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
71455298 82341 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172166 82341 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11950328 197278 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 197278 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272880 195483 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 195483 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272036 195586 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 195586 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271155 195640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 195640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272880 195483 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552973 195483 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272036 195586 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL555342 195586 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271155 195640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556330 195640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140162 199473 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591593 199473 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139945 200210 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL596732 200210 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
45139953 201022 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL602294 201022 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232922 199272 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590255 199272 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66854919 82307 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172130 82307 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487838 197309 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 197309 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
66854714 82314 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
CHEMBL2172137 82314 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
45485854 197476 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569908 197476 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123180 14834 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207384 14834 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL401859 14834 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46233668 200245 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL596962 200245 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
45272035 195089 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 195089 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485893 196756 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565249 196756 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485857 197477 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 197477 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11670815 197200 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 197200 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
66856844 82332 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172156 82332 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141776 199643 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592887 199643 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
9953334 94386 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250848 94386 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45271128 194928 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 194928 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25125168 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25125168 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208098 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208098 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496401 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496401 14918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45487813 197083 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 197083 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44128982 82318 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172142 82318 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45140353 200340 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
CHEMBL597563 200340 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
87791 14925 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL1208117 14925 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL498229 14925 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
45485900 197517 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 197517 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 197547 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 197547 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485953 197565 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 197565 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140551 199631 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592825 199631 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24786234 139747 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 minsDisplacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 mins
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.5b01972
CHEMBL3798413 139747 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 minsDisplacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 mins
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.5b01972
46232951 199221 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589901 199221 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232945 200898 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601486 200898 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485936 197054 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 197054 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 197522 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 197522 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141579 199261 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590140 199261 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140938 199397 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591048 199397 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140748 199640 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592884 199640 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631974 200967 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 200967 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485859 197460 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 197460 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 197524 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 197524 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485911 197508 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 197508 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233229 198435 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577236 198435 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140932 199602 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592678 199602 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233329 198661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579330 198661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141981 199180 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589554 199180 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139771 201133 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603147 201133 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140928 201333 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604288 201333 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485888 196961 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 196961 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485956 197566 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 197566 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141986 198338 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL576331 198338 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141134 198515 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577844 198515 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139769 199588 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592577 199588 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232944 199267 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590194 199267 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9823796 154037 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398434 154037 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485908 197512 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 197512 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142445 199351 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590744 199351 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139772 199353 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590746 199353 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142223 200776 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600573 200776 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140365 201136 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603150 201136 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232893 199237 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590004 199237 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232941 200896 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601484 200896 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485896 196779 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 196779 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485933 197525 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 197525 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233233 198540 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578080 198540 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141128 199307 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590418 199307 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485935 197050 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 197050 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485855 197473 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 197473 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233327 198626 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578899 198626 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140558 199382 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590990 199382 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140165 201138 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603152 201138 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232883 199210 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589824 199210 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 200968 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 200968 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232917 200999 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602111 200999 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485918 196974 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 196974 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 197494 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 197494 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855197 82364 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172273 82364 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45269472 196339 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562405 196339 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141582 198574 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578335 198574 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140160 200553 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599005 200553 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66856952 82311 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172134 82311 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487850 196996 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 196996 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45272846 195654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 195654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66856999 82313 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172136 82313 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272902 195715 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 195715 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24830601 200654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599605 200654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128138 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
CHEMBL1208159 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
CHEMBL502519 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
44610760 197310 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 197310 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45269472 196339 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 196339 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25128138 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208159 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL502519 14932 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46232936 200864 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601276 200864 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
39073052 196981 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566661 196981 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
67204 14943 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208280 14943 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL521709 14943 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
45487790 198982 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 198982 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270294 195328 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 195328 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129522 82336 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172160 82336 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485881 197479 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569911 197479 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485901 197520 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 197520 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855285 82340 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172165 82340 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141772 199125 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589198 199125 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141982 199352 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590745 199352 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140936 199421 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591226 199421 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232915 199225 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589930 199225 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232925 199273 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590256 199273 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487789 197157 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 197157 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16066663 78148 38 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
CHEMBL2103828 78148 38 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
45269461 196194 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 196194 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16066663 78148 38 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
CHEMBL2103828 78148 38 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
44128901 82304 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172127 82304 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129058 82309 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172132 82309 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487789 197157 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 197157 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66854417 82334 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172158 82334 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
6689 14914 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208089 14914 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL495834 14914 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
45273818 194848 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 194848 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70683418 73971 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021587 73971 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44583582 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
5904 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
59448166 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL1207916 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL455536 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
45487837 199009 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 199009 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
11955421 199041 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 199041 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
66919940 82367 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172279 82367 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271978 195023 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549308 195023 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271978 195023 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549308 195023 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
167524 14667 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1205665 14667 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL131271 14667 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
66919996 82369 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172280 82369 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44583582 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
5904 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
59448166 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL1207916 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL455536 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
20299057 60258 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1672103 60258 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1741093 60258 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
46233230 199501 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591874 199501 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232886 200929 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601694 200929 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25114519 14946 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208288 14946 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524064 14946 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268619 195506 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 195506 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70687668 73970 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021586 73970 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232932 200863 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601275 200863 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485853 197353 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 197353 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270323 195247 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 195247 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271092 196444 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 196444 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487817 197277 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 197277 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
44129524 82365 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172274 82365 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271092 196444 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563041 196444 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269465 196254 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 196254 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66919958 82371 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172282 82371 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233130 200524 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598821 200524 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268594 195563 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 195563 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233324 199638 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL592882 199638 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45139949 200446 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
CHEMBL598376 200446 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
45139765 200522 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598816 200522 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128387 82355 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172264 82355 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233096 201617 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605847 201617 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485903 197518 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 197518 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271984 195088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 195088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
10202847 199024 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585852 199024 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45271984 195088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549724 195088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232903 199239 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590006 199239 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487843 197193 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 197193 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487817 197277 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 197277 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
10109037 197114 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567695 197114 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45485934 196976 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 196976 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 197745 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 197745 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 196953 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 196953 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233228 198516 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577854 198516 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139768 199628 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592810 199628 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485967 197545 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 197545 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855732 82324 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172148 82324 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44443933 98286 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL274713 98286 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
46233237 198658 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579289 198658 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 199184 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589584 199184 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140366 200726 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600055 200726 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 199184 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589584 199184 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142219 199268 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590208 199268 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140930 199294 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590364 199294 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140937 199422 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591227 199422 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232947 200899 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601487 200899 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485954 197554 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 197554 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 194849 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
CHEMBL539733 194849 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
45272869 195482 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552972 195482 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140931 199348 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590741 199348 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232935 199246 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590069 199246 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485960 197126 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 197126 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 197568 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 197568 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233328 198640 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579081 198640 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140557 199364 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590798 199364 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485902 197425 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 197425 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140939 199414 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591185 199414 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139587 199586 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592563 199586 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139950 199589 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592581 199589 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139766 199627 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592806 199627 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272869 195482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 195482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45140556 200271 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597150 200271 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232830 199173 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589520 199173 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142221 199139 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589283 199139 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128980 82319 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
CHEMBL2172143 82319 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
44129445 82357 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172266 82357 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45485860 197461 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 197461 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 197237 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 197237 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45487850 196996 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 196996 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45268630 196088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560748 196088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139401 200684 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599825 200684 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232937 199276 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590259 199276 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232924 200858 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601270 200858 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233589 200274 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597158 200274 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11649278 14915 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208091 14915 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496022 14915 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268630 196088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 196088 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
121990 75 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1710 75 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1763 75 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
CHEMBL435402 75 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
45487837 199009 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 199009 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
45270288 195272 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 195272 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 195272 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551217 195272 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272881 194861 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 194861 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129449 82339 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172163 82339 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272881 194861 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539983 194861 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140156 200626 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599400 200626 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272055 194893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 194893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272055 194893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540737 194893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485895 197265 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568498 197265 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270296 195329 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 195329 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11955421 199041 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 199041 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45270296 195329 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551620 195329 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273812 195756 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL557535 195756 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271082 195479 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552921 195479 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233355 200549 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598998 200549 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271145 194929 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 194929 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273812 195756 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 195756 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487800 198980 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 198980 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272074 195343 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551750 195343 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233323 201643 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL605964 201643 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
6451084 54962 51 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL1615434 54962 51 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45487843 197193 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 197193 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487841 196803 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 196803 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487809 196952 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 196952 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44125995 82366 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172278 82366 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45267776 196233 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561692 196233 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233322 200655 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599606 200655 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
25124828 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124828 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208131 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208131 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499580 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL499580 14931 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485891 196990 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566753 196990 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45487844 199042 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 199042 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270314 195145 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 195145 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45140746 201710 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL606408 201710 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11955422 196881 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 196881 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
44610760 197310 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 197310 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45141131 199171 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589518 199171 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140929 200936 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601704 200936 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141131 199171 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589518 199171 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232897 199216 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589889 199216 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232881 199227 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589971 199227 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485892 197035 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 197035 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233232 198584 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578482 198584 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485937 197247 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 197247 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139588 199626 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592802 199626 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485947 197546 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 197546 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232891 200932 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601697 200932 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140166 199355 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590748 199355 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485880 197573 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570423 197573 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141987 199137 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589281 199137 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140364 199587 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592570 199587 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140159 199636 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592880 199636 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139406 200754 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600371 200754 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232907 199240 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590007 199240 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139958 199354 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590747 199354 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233235 199532 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592166 199532 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485890 197483 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 197483 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140935 199535 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592195 199535 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232898 200965 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601904 200965 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233326 198569 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578271 198569 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233223 199529 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592163 199529 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232912 200971 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601910 200971 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45272054 194892 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 194892 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
44128981 82320 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172144 82320 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
44129448 82360 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172269 82360 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11955422 196881 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 196881 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
45485865 197364 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569127 197364 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829780 196465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 196465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128900 82308 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172131 82308 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44128468 82333 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172157 82333 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
24829780 196465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563183 196465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233175 200217 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596769 200217 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140157 200480 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598588 200480 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271100 196674 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 196674 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 196674 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564552 196674 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233239 199560 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592408 199560 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139948 200445 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
CHEMBL598375 200445 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
1149185 197192 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568126 197192 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45487842 198984 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 198984 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487813 197083 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 197083 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140750 199507 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591945 199507 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140743 200448 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598386 200448 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140744 200482 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL598594 200482 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45272842 195624 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 195624 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129525 82372 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172284 82372 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487800 198980 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 198980 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140154 200590 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
CHEMBL599197 200590 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
45487844 199042 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 199042 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270322 194782 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 194782 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45139947 200444 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
CHEMBL598374 200444 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
45269483 194793 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 194793 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66855932 82331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172155 82331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45270266 195072 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549594 195072 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233354 200680 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599816 200680 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
45267750 195927 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 195927 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267750 195927 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559340 195927 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140158 201644 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605968 201644 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485939 197150 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 197150 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 197237 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 197237 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44129136 82305 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172128 82305 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855902 82326 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
CHEMBL2172150 82326 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
45141129 199341 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590673 199341 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141584 199641 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592885 199641 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232934 199254 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590114 199254 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44443938 94175 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249584 94175 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9850430 94205 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249789 94205 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9846875 94344 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 94344 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 94344 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
18717762 94385 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250847 94385 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45141985 198662 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579334 198662 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485885 197220 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568257 197220 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232914 200996 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602109 200996 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485941 197021 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 197021 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142220 199089 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL588492 199089 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142452 199644 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592888 199644 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139589 200752 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600369 200752 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142451 200779 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600576 200779 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140367 200727 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600056 200727 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142453 199138 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589282 199138 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141580 199288 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590328 199288 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140749 199498 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591839 199498 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232946 199278 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590261 199278 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232926 200859 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601271 200859 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485862 197478 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 197478 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270274 195758 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL557553 195758 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
66854841 82322 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172146 82322 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
46233231 199531 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592165 199531 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141344 200361 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597772 200361 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485905 197521 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 197521 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233236 198641 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579094 198641 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139773 199056 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL586227 199056 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140368 200728 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600057 200728 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485919 196790 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 196790 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139403 199580 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592531 199580 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232913 200995 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602108 200995 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232919 201000 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602112 201000 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
11585281 14930 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208129 14930 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499428 14930 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123181 14920 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1208106 14920 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL496820 14920 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
66856658 82330 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
CHEMBL2172154 82330 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
44631970 194849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 194849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 194849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 194849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
71449929 82356 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172265 82356 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 196845 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 196845 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856790 82328 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
CHEMBL2172152 82328 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
45140927 199179 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589550 199179 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233133 199458 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591510 199458 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25123181 14920 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208106 14920 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496820 14920 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485851 197432 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 197432 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233132 201160 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603333 201160 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66854424 82337 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172161 82337 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855084 82338 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172162 82338 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129447 82359 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172268 82359 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66920261 82370 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172281 82370 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 196845 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 196845 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45141133 198573 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578324 198573 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233224 200657 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599634 200657 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232892 199211 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589828 199211 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139957 201135 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603149 201135 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233225 198467 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577433 198467 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232906 199195 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589697 199195 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232918 199242 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590009 199242 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44631974 200967 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 200967 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9846875 94344 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 94344 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 94344 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
66854759 82310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172133 82310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141771 199350 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590743 199350 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141984 199516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592021 199516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232888 199218 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589897 199218 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232901 199238 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590005 199238 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 200968 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 200968 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485909 197513 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 197513 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139586 199616 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592737 199616 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139402 200660 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599637 200660 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45270314 195145 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL550206 195145 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
66854409 82335 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172159 82335 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233131 200555 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599020 200555 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25127813 14913 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208083 14913 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL495605 14913 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45142446 200360 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597765 200360 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25124162 60259 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1671994 60259 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1741096 60259 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
25128136 14888 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207855 14888 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL446904 14888 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45273789 195907 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 195907 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45273789 195907 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL559126 195907 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45141130 199141 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589290 199141 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44129446 82358 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172267 82358 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
9969173 198476 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL577508 198476 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
25123183 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
25123183 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL1208235 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL1208235 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL509572 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL509572 14936 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
25124484 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124484 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206415 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206415 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271672 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL271672 14750 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45269454 196118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 196118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142449 196330 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 196330 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487821 197118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 197118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45269454 196118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561007 196118 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142449 196330 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562344 196330 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
136677322 3296 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
1739 3296 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
656725 3296 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
CHEMBL1160031 3296 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
45270321 195519 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 195519 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
45139400 200241 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596939 200241 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 194850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 194850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 196722 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 196722 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 196722 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564981 196722 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141585 199373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590939 199373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485942 197527 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 197527 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232948 200900 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601488 200900 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855824 82363 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172272 82363 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46232928 200861 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601273 200861 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485940 196760 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565300 196760 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485916 196901 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 196901 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139590 200780 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600577 200780 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485913 197790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571929 197790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139591 200417 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598160 200417 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232880 199226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589961 199226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141583 198606 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578714 198606 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142450 200777 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600574 200777 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
5906 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
66855377 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
CHEMBL2172140 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
5906 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
66855377 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
CHEMBL2172140 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
44129369 82327 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
CHEMBL2172151 82327 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
45140933 199447 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591427 199447 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139952 200244 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596961 200244 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139956 201134 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603148 201134 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232889 199236 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590003 199236 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485883 197481 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569913 197481 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123505 14922 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL1208113 14922 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL498038 14922 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
44129371 82323 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172147 82323 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
45485852 197424 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 197424 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270267 195095 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549797 195095 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233357 201580 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605565 201580 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
13782419 14751 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206416 14751 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271673 14751 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
11670815 197200 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 197200 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
45273782 195508 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 195508 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273782 195508 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL553654 195508 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487842 198984 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 198984 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487790 198982 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 198982 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45139946 200211 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596733 200211 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
20638786 154962 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL401158 154962 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
11950159 197115 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 197115 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233176 201371 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604497 201371 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232885 199235 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590002 199235 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485948 197564 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570384 197564 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140753 199361 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590771 199361 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232905 199188 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589616 199188 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485945 197078 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 197078 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485951 197551 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570271 197551 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 197744 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 197744 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140752 199370 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590856 199370 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140362 199441 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591367 199441 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232909 199224 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589927 199224 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233227 199530 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592164 199530 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232908 200969 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601908 200969 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140163 199332 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590602 199332 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140555 199381 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590989 199381 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139954 200623 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599397 200623 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232910 200970 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601909 200970 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45269484 195665 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 195665 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
66857005 82329 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
CHEMBL2172153 82329 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
45270295 194771 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 194771 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128983 82317 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172141 82317 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45487838 197309 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 197309 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
46233095 199418 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL591212 199418 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
46233134 199464 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
CHEMBL591536 199464 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
16681707 759 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
1767 759 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
CHEMBL2172275 759 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
46233451 200390 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597980 200390 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128135 14919 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208102 14919 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496620 14919 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45140161 199482 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591691 199482 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
168293759 192167 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5203993 192167 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
46233174 200689 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599843 200689 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141773 201130 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603144 201130 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233226 198486 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577653 198486 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233238 199559 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592407 199559 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485921 197018 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 197018 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485894 197453 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 197453 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141345 198469 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577454 198469 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140363 199601 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592671 199601 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141578 199279 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590262 199279 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272861 195481 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552971 195481 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141774 199642 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592886 199642 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232929 199274 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590257 199274 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45267728 196206 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 196206 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268641 194838 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 194838 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142447 200423 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598177 200423 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139764 200483 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL598612 200483 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
45269473 196340 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 196340 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
71462475 82362 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172271 82362 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45267722 196100 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 196100 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 196100 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560882 196100 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
22916 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
22916 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206272 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206272 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL256057 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL256057 14725 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45270300 195397 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 195397 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273811 196497 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 196497 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270300 195397 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552022 195397 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
1756 463 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
5310954 463 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
CHEMBL336292 463 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
60606 61560 73 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
CHEMBL1771 61560 73 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
1765 3817 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3817 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3817 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3817 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3817 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1765 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
4184 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
9871419 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
CHEMBL398435 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
DB08816 3817 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
1712 288 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
6022 288 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
CHEMBL14830 288 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
44126037 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
5905 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
CHEMBL2172277 1111 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
44583582 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
5904 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
59448166 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL1207916 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL455536 3204 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
1765 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
4184 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
9871419 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
CHEMBL398435 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
DB08816 3817 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
23649325 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
23649325 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
7360 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
7360 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
CHEMBL2419490 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
CHEMBL2419490 541 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
5906 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
66855377 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
CHEMBL2172140 1024 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
121990 75 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1710 75 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1763 75 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
CHEMBL435402 75 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
10000627 3016 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
11136 3016 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
1773 3016 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
56947084 3016 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
10066813 956 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474
1772 956 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474